Literature DB >> 1997647

Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.

R Bucala1, C Ritchlin, R Winchester, A Cerami.   

Abstract

Conditioned media obtained from fibroblasts cultured from rheumatoid and certain other inflammatory synovia were observed to stimulate [3H]thymidine incorporation in an indicator murine fibroblast line. Synovial fibroblasts derived from the joints of patients with osteoarthritis did not display this property. This effect persisted in culture for many weeks and occurred in the absence of co-stimulatory immune cells. Antibody neutralization studies implicated a role for basic fibroblast growth factor (bFGF), transforming growth factor beta (TGF-beta), granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin 1 beta (IL-1 beta) in the increased proliferative activity of synovial fibroblast-conditioned media. Synovial cell synthesis of bFGF, TGF beta 1, GM-CSF, IL-1 beta, and IL-6 was confirmed by 35S-methionine labeling and immunoprecipitation. The constitutive production of inflammatory and mitogenic cytokines by synovial fibroblasts may represent the result of long-term, phenotypic changes that occurred in vivo. Persistent cytokine production by synovial fibroblasts may play an important role in the continued recruitment and activation of inflammatory cells in chronic arthritis and in the formation of rheumatoid pannus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997647      PMCID: PMC2118837          DOI: 10.1084/jem.173.3.569

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Isolation and structure of urogastrone and its relationship to epidermal growth factor.

Authors:  H Gregory
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

2.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

3.  Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor.

Authors:  V O Melnyk; G D Shipley; M D Sternfeld; L Sherman; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  1990-04

4.  Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

Authors:  J M Dayer; J Bréard; L Chess; S M Krane
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

5.  Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts.

Authors:  G R Burmester; A Dimitriu-Bona; S J Waters; R J Winchester
Journal:  Scand J Immunol       Date:  1983-01       Impact factor: 3.487

6.  Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders.

Authors:  M DeGré; O J Mellbye; O Clarke-Jenssen
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

7.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

9.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.

Authors:  A Dimitriu-Bona; G R Burmester; S J Waters; R J Winchester
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

10.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  71 in total

1.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

Authors:  C Langdon; C Kerr; M Hassen; T Hara; A L Arsenault; C D Richards
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

Review 3.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

4.  Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts.

Authors:  Sohel M Julovi; Kaitlin Shen; Kelly Mckelvey; Nikita Minhas; Lyn March; Christopher J Jackson
Journal:  Mol Med       Date:  2013-10-24       Impact factor: 6.354

5.  Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells.

Authors:  M Schneider; B Voss; J Rauterberg; M Menke; T Pauly; R K Miehlke; J Friemann; U Gerlach
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

6.  Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.

Authors:  S Wakisaka; N Suzuki; M Takeno; Y Takeba; H Nagafuchi; N Saito; H Hashimoto; T Tomita; T Ochi; T Sakane
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

7.  Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene.

Authors:  T Nakajima; H Aono; T Hasunuma; K Yamamoto; I Maruyama; T Nosaka; M Hatanaka; K Nishioka
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro.

Authors:  D L Mattey; E Evans; P T Dawes
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

10.  Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.

Authors:  M Hogan; A Cerami; R Bucala
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.